InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Stejbach Mark, Director. Insider active across 2 companies, notably Flexion Therapeutics Inc. Cumulatively, 6 filings have been published. The latest transaction was disclosed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
06,518 shares0
Common Stock
SEC:0001487937-26-000009:0·
06,518 shares0
Common Stock
SEC:0001487937-26-000009·
€94,44012,631 shares@ €7.4769100.0% of flow
Common Stock
SEC:0001209191-21-065722·
€94,44012,631 shares@ €7.476950.0% of flow
Common Stock
SEC:0001209191-21-065722:0·
04,500 shares0
Common Stock
SEC:0001209191-21-043552·
04,500 shares0
Common Stock
SEC:0001209191-21-043552:0·
6 of 6 declarations
About Stejbach Mark
Mark Stejbach is a Board Member of Flexion Therapeutics Inc. and Indivior Pharmaceuticals, Inc. He brings expertise in corporate strategy and governance. His role on the boards allows him to actively participate in strategic decision-making for these companies. Through his experience, he helps guide growth initiatives and strengthen their market positions.
